Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07295678Not yet recruiting
Open-label trial in atopic dermatitis (AD), sponsored by CEN Biotech. Primary endpoint: Local SCORAD Index at 30 days. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07295678.